The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Brazil’s Ambipar opens offices in Dubai, Abu Dhabi
- Saudi Arabia opens yerba mate market to Brazil
- Brazil export: Interest rate equalization prepaid
- Algeria to expand agricultural financing in 2025
- Brazil re-enters UNESCO alliance
- Climate events could affect Mauritania’s economy
- Saudi art exhibition in Rio offers poetic journey
- Morocco’s women rug weavers save age-old craft